aptorum group ltd - APM

APM

Close Chg Chg %
1.11 -0.05 -4.50%

Closed Market

1.06

-0.05 (4.50%)

Volume: 41.20K

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Company Overview: aptorum group ltd - APM

APM Key Data

Open

$1.10

Day Range

1.06 - 1.15

52 Week Range

0.69 - 4.80

Market Cap

$9.04M

Shares Outstanding

8.14M

Public Float

5.31M

Beta

-0.21

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

52.12K

 

APM Performance

1 Week
 
-2.63%
 
1 Month
 
-17.78%
 
3 Months
 
-50.67%
 
1 Year
 
-60.36%
 
5 Years
 
-95.51%
 

APM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About aptorum group ltd - APM

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

APM At a Glance

Aptorum Group Ltd.
17 Hanover Square
London, Greater London W1S 1BN
Phone 44-20-8092-9299 Revenue 0.00
Industry Pharmaceuticals: Major Net Income -4,267,806.00
Sector Health Technology Employees 1
Fiscal Year-end 12 / 2025
View SEC Filings

APM Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 0.743
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.392
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.405

APM Efficiency

Revenue/Employee N/A
Income Per Employee -4,267,806.00
Receivables Turnover N/A
Total Asset Turnover N/A

APM Liquidity

Current Ratio 0.221
Quick Ratio 0.221
Cash Ratio 0.201

APM Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -23.213
Return on Equity -18.563
Return on Total Capital -17.371
Return on Invested Capital -17.365

APM Capital Structure

Total Debt to Total Equity 16.251
Total Debt to Total Capital 13.979
Total Debt to Total Assets 21.293
Long-Term Debt to Equity 0.067
Long-Term Debt to Total Capital 0.058
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aptorum Group Ltd - APM

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
- 1.54M 1.30M 431.38K
Sales Growth
+69.15% -15.95% -66.71% -100.00%
Cost of Goods Sold (COGS) incl D&A
2.65M 2.42M 1.55M 255.05K
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.19M 1.21M 1.13M 255.05K
Depreciation
1.09M 1.09M 1.04M 235.83K
Amortization of Intangibles
106.01K 114.55K 84.02K 19.22K
COGS Growth
+12.89% -8.64% -36.20% -83.50%
Gross Income
(1.11M) (1.13M) (1.11M) (255.05K)
Gross Income Growth
+22.77% -1.51% +1.13% +77.12%
Gross Profit Margin
- -72.04% -87.00% -258.40%
2021 2022 2023 2024 5-year trend
SG&A Expense
17.70M 16.12M 8.54M 3.41M
Research & Development
9.91M 8.16M 4.13M 1.94M
Other SG&A
7.80M 7.97M 4.41M 1.47M
SGA Growth
-1.42% -8.94% -47.01% -60.05%
Other Operating Expense
392.51K 261.04K 866.77K 128.56K
Unusual Expense
- - 200.92K 1.14M
-
EBIT after Unusual Expense
(19.21M) (17.51M) (10.72M) (4.94M)
Non Operating Income/Expense
(7.81M) 5.98M 6.50M 929.73K
Non-Operating Interest Income
- - - 146.59K
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 93.60K 121.14K 146.92K
Interest Expense Growth
- - -61.58% +21.28%
-
Gross Interest Expense
- 93.60K 121.14K 146.92K
Interest Capitalized
- - - -
-
Pretax Income
(27.11M) (11.53M) (4.34M) (4.16M)
Pretax Income Growth
-651.08% +57.49% +62.33% +4.22%
Pretax Margin
- -1,758.64% -889.36% -1,006.30%
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(27.11M) (11.53M) (4.34M) (4.16M)
Minority Interest Expense
(2.07M) (1.73M) (1.52M) 110.07K
Net Income
(25.05M) (9.80M) (2.82M) (4.27M)
Net Income Growth
-454.45% +60.88% +71.18% -51.09%
Net Margin Growth
- -1,624.64% -756.20% -654.80%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(25.05M) (9.80M) (2.82M) (4.27M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(25.05M) (9.80M) (2.82M) (4.27M)
EPS (Basic)
-7.1497 -2.7454 -0.6248 -0.7826
EPS (Basic) Growth
-452.72% +61.60% +77.24% -25.26%
Basic Shares Outstanding
3.50M 3.57M 4.52M 5.45M
EPS (Diluted)
-7.1497 -2.7454 -0.6248 -0.7826
EPS (Diluted) Growth
-457.23% +61.60% +77.24% -25.26%
Diluted Shares Outstanding
3.50M 3.57M 4.52M 5.45M
EBITDA
(18.01M) (16.30M) (9.40M) (3.54M)
EBITDA Growth
+2.94% +9.51% +42.35% +62.32%
EBITDA Margin
- -1,168.45% -1,257.95% -2,178.62%

Aptorum Group Ltd in the News